WFI Beyond - Beyond Compendial

WFI Beyond - the water standard inside every GMP biologic, from monoclonal antibodies and mRNA to cell, gene and vaccine therapies.

1. Founded on water

In 1988, in the village of Aidenbach in Lower Bavaria, PAN-Biotech was founded for one simple reason: the water. The region sits on what the company’s founders considered some of the finest well water in Europe - and the conviction was not eccentric. A few kilometres away, the Cistercian monks of Kloster Aldersbach had been brewing beer on the very same groundwater since 1268 - a brewery documented from that year, and among the oldest in the world. And the parallel runs deeper than the water alone: brewing is itself a biological process - yeast cultured in water to harvest a product - the very principle on which modern cell culture, and the biologics industry PAN-Biotech serves, is built. Good water has been prized in this corner of Bavaria for the better part of a millennium.

For the thirty-eight years since, that water has been the quiet foundation of PAN-Biotech’s cell-culture media - the products that made the company’s name with biologics developers worldwide. Then PAN-Celltech was founded to carry that same foundation forward into GMP: to bring the group’s decades of water and bioprocess expertise to the demands of regulated, clinical-grade manufacturing.

2. The most underestimated raw material

In any biologics process, Water for Injection is everywhere and noticed nowhere. It is the base of almost every buffer and medium, and it is the vehicle for the final formulation that goes into the vial. No other single input touches so many stages of the process - or so many different kinds of processes.

That ubiquity is exactly why it is dangerous to underestimate. Because the water flows into nearly every step, its quality cascades into all of them: a deficiency in the water is not contained to one buffer, it is distributed across the entire process. The most ordinary-looking component is, at GMP scale, one of the hardest to guarantee consistently and to document - and the one whose quality is most quietly multiplied through everything it touches.

3. One water, every modality

What makes WFI unique among raw materials is that it is not specific to any one product. Antibodies, mRNA, cell and gene therapies, vaccines and recombinant proteins are built on profoundly different biology - but all of them rest on the same water. That is why a single, premium water standard can serve an entire pipeline, even as the molecules it supports could hardly be more different.

What changes from one modality to the next is not whether water quality matters, but which attribute matters most. The same WFI Beyond specification answers all of them; each application simply leans on a different part of it:

Read down the table and the conclusion is hard to miss: the case for a higher water standard does not weaken as you move beyond antibodies - it strengthens. For mRNA and cell and gene therapy in particular, the attributes that distinguish a premium WFI are not a refinement; they are central to whether the product works at all.

4. Beyond the monograph: what a premium water controls

“Water for Injection” is a pharmacopeial grade. To carry the name, water must meet a defined monograph - limits on conductivity, organic carbon, endotoxin and so on. That is a meaningful bar. But it is a floor, not a ceiling: it describes the minimum a water must clear to be called WFI, not the quality a particular batch delivers. Two waters can both be entirely legitimate WFI and still be worlds apart on the attributes that matter to an advanced biologic, because the monograph was written for injectable water in general - not for the specific vulnerabilities of these molecules. The European standard for it dates back to the first European Pharmacopoeia, published in 1969, its limits framed in, and for, the medicine of that era.

That era was the age of small-molecule and classical injectable drugs; the biologics that dominate today’s pipelines did not yet exist. The monograph has been maintained ever since - the European Pharmacopoeia still required Water for Injection to be produced by distillation as late as 2017 - but its core definition of “good enough” was set for a world of simpler molecules. WFI Beyond starts from the other end: it is engineered for the medicine of today and tomorrow - built around exactly the attributes those modern modalities depend on, rather than the baseline an earlier era found sufficient.

Each of those vulnerabilities maps to a specific attribute of the water:

• Endotoxin. Pyrogenic and a direct patient-safety concern. The compendial limit (0.25 EU/mL) is a ceiling not to be exceeded - but the goal for a biologic is to sit as far below it as possible, not merely to clear it.
• Nucleases. Residual RNase and DNase degrade nucleic acids - a quiet source of variability for antibodies and analytical work, and a direct potency risk for mRNA and gene therapies.
• Trace / elemental impurities. Copper and iron - the two metals that catalyse antibody oxidation by Fenton chemistry and drive aggregation - are a direct threat to protein stability and shelf life that conductivity alone does not capture; and one of them, iron, sits beyond what the water monograph or even ICH Q3D asks you to measure.
• Organic carbon (TOC). A general marker of purity: the lower the organic load, the fewer unknowns introduced into a sensitive process.
• Animal origin. A TSE/BSE and animal-component question runs through every regulatory filing. A clear animal-component-free position closes it before it is asked.

And the questions no longer end where the 1969 monograph does. A biologic reaching a patient today must account for impurity classes the monograph never named - and WFI Beyond addresses each of them in its documentation: elemental impurities to ICH Q3D (all 24 elements, by validated ICP-MS), residual solvents to ICH Q3C, nitrosamines to current EMA guidance - the class that forced global drug recalls from 2018 onward - and TSE/BSE safety, from exclusively non-animal materials outside the scope of EMA/410/01 Rev. 3. That is the impurity dossier a modern filing actually has to clear, prepared in advance and backed by a signed declaration.

5. The WFI Beyond standard

WFI Beyond is built to go beyond the monograph on exactly the attributes that matter - across every modality. “Beyond compendial” is not a slogan; it is a measured fact, certified lot by lot on the Certificate of Analysis. The proof reads in three columns - the pharmacopoeia floor, the WFI Beyond specification, and a typical measured result - so the gap is visible, not asserted:

Made and assured under GMP.

WFI Beyond is manufactured by PAN-Celltech under EU GMP Annex 1 within an ISO 9001 quality system. Aseptic filling is validated by routine media fills performed twice a year, in line with Annex 1. And it is backed by an ICH-format stability study supporting a two-year shelf life - tracked on sterility and endotoxin, at +15 to +25 °C. For a raw material that feeds an entire process, a proven shelf life and a validated aseptic process are not details; they are part of the assurance the product carries, from delivery through use.

Sterility and single-use. The water is sterile-filtered through a 0.1 µm filter - a full grade tighter than the 0.2 µm sterilising filter most processes rely on, and into the range that also retains mycoplasma-sized organisms - and is then filled aseptically into single-use containers that have themselves been gamma-irradiated (Cobalt-60) before filling, to a validated dose under ISO 11137 reaching a Sterility Assurance Level of 10⁻⁶, the pharmaceutical one-in-a-million standard. The container-closure system is qualified for both bottles and bags, and the film screened for extractables - DEHP and other phthalates, Bisphenol A, dioxin and melamine were not identified.

6. From source to single-use bag

A premium source is the beginning of the story, not the end of it. WFI quality is ultimately made by purification and control, not by the well alone - and then proven by testing and documentation. Every lot is characterised against the attribute panel above and supplied with a Certificate of Analysis. Under GMP, that documentation is not paperwork around the product - it is part of the product.

The regulatory keystone.

Of everything in that package, the Drug Master File does the most work. WFI Beyond is backed by a Type IV (excipient) Drug Master File filed with the US FDA (MF044505); the group also holds a filed DPBS Type IV (excipient) DMF (MF044371). A DMF on file lets you reference our confidential manufacturing and quality data directly in your own regulatory submission - through a simple letter of authorisation - so the authority can rely on it in full without your team ever obtaining, holding or recreating it, and without proprietary detail being exposed in either direction. It removes one of the heaviest items a lean QA function would otherwise build from scratch, and it measurably de-risks and shortens your filing. For an input as fundamental as water, a DMF is the difference between buying from a supplier and building on a regulatory partner.

Single-use where it touches the product. WFI Beyond is made and filled on a single-use, gamma-irradiated product-contact path. Every product-contact part is single-use and replaced for each batch, so there is no shared, multi-product equipment and no cleaning-residue or batch-to-batch carry-over on the product-contact path.

It scales seamlessly with your programme - from 500 ml and 1000 ml bottles (CT-981500, CT-981000) to single-use, gamma-irradiated bags from 1 to 1000 litres (CT-98001B, CT-98005B, CT-98010B, CT-98020B, CT-98050B, CT-98200B, CT-98500B, CT-981000B) - so the same qualified water follows you from development to production, and across every modality in your pipeline, without re-qualifying the supply at every step.

7. Conclusion

Water is the input every biologics process takes for granted and the one whose quality reaches furthest. “Meets WFI” tells you a water cleared the floor; it does not tell you whether it was made for your molecule. WFI Beyond is nuclease-free, animal-component-free, low in organic carbon and elemental impurities, sterile and single-use, with endotoxin more than fifty times below the compendial limit and organic carbon ten times below it - all certified on a Certificate of Analysis and backed by a filed FDA Drug Master File.

Because it is the one standard shared by antibodies, mRNA, cell and gene therapies and vaccines alike, WFI Beyond can sit beneath an entire pipeline - a single qualified water you grow with, whatever you are making. It comes, fittingly, from a group founded on water in 1988 and built to bring it to GMP. For a modern biologic, that foundation is not a nice story - it is the difference between water that complies and water that protects.

Frequently asked questions